Author:
Bonneterre J.,Spielman M.,Guastalla J.-P.,Marty M.,Viens P.,Chollet P.,Roché H.,Fumoleau P.,Mauriac L.,Bourgeois H.,Namer M.,Bergerat J.P.,Misset J.-L.,Trandafir L.,Mahjoubi M.
Reference30 articles.
1. Systemic therapy of advanced breast cancer;Mouridsen;Drugs,1992
2. Survival outcome from a cohort of 953 metastatic breast cancer patients reffered and treated in a single institution during the last 40 years;Rouësse;Proc. Am. Soc. Clin. Oncol.,1996
3. Taxotere versus mitomycin C and vinblastine in patients with metastatic breast cancer who have failed an anthracycline-containing regimen;Nabholtz;Proc. Am. Soc. Clin. Oncol.,1997
4. Vinorelbine (navelbine) as a salvage treatment for advanced breast cancer;Degardin;Ann. Oncol,1994
5. Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer;Jones;J. Clin. Oncol,1995
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献